Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Protagonist Therapeutics, Inc (PTGX)

Ali Asif — Chief Financial Officer
Jan 27, 2026
Sale
Shares
28,000
Price
$83.13
Total Value
$2.33M
Shares Held After
78,523
% of Holdings
26.3%

Protagonist Therapeutics, Inc (PTGX)

MOLINA ARTURO MD — Chief Medical Officer
Jan 27, 2026
Sale
Shares
5,000
Price
$82.00
Total Value
$410.00K
Shares Held After
84,115
% of Holdings
5.6%

Kura Oncology, Inc. (KURA)

Powl Brian T. — Chief Commercial Officer
Jan 27, 2026
Sale
Shares
1,572
Price
$8.46
Total Value
$13.30K
Shares Held After
183,275
% of Holdings
0.9%

Kura Oncology, Inc. (KURA)

Powl Brian T. — Chief Commercial Officer
Jan 27, 2026
Sale
Shares
4,842
Price
$8.46
Total Value
$40.97K
Shares Held After
184,847
% of Holdings
2.6%

Kura Oncology, Inc. (KURA)

FORD KATHLEEN — Chief Operating Officer
Jan 27, 2026
Sale
Shares
1,813
Price
$8.46
Total Value
$15.34K
Shares Held After
153,560
% of Holdings
1.2%

Kura Oncology, Inc. (KURA)

Leoni Mollie — Chief Medical Officer
Jan 27, 2026
Sale
Shares
1,341
Price
$8.46
Total Value
$11.35K
Shares Held After
267,274
% of Holdings
0.5%

Kura Oncology, Inc. (KURA)

Leoni Mollie — Chief Medical Officer
Jan 27, 2026
Sale
Shares
951
Price
$8.46
Total Value
$8.05K
Shares Held After
268,615
% of Holdings
0.4%

Kura Oncology, Inc. (KURA)

Leoni Mollie — Chief Medical Officer
Jan 27, 2026
Sale
Shares
2,233
Price
$8.46
Total Value
$18.89K
Shares Held After
269,566
% of Holdings
0.8%

Kura Oncology, Inc. (KURA)

Leoni Mollie — Chief Medical Officer
Jan 27, 2026
Sale
Shares
3,655
Price
$8.46
Total Value
$30.92K
Shares Held After
271,799
% of Holdings
1.3%

Kura Oncology, Inc. (KURA)

DOYLE THOMAS JAMES — SVP, Finance & Accounting
Jan 27, 2026
Sale
Shares
881
Price
$8.46
Total Value
$7.45K
Shares Held After
145,167
% of Holdings
0.6%

Kura Oncology, Inc. (KURA)

DOYLE THOMAS JAMES — SVP, Finance & Accounting
Jan 27, 2026
Sale
Shares
2,226
Price
$8.46
Total Value
$18.83K
Shares Held After
146,048
% of Holdings
1.5%

Kura Oncology, Inc. (KURA)

DOYLE THOMAS JAMES — SVP, Finance & Accounting
Jan 27, 2026
Sale
Shares
695
Price
$8.46
Total Value
$5.88K
Shares Held After
148,274
% of Holdings
0.5%

Kura Oncology, Inc. (KURA)

DOYLE THOMAS JAMES — SVP, Finance & Accounting
Jan 27, 2026
Sale
Shares
1,114
Price
$8.46
Total Value
$9.43K
Shares Held After
148,969
% of Holdings
0.7%

Kura Oncology, Inc. (KURA)

DOYLE THOMAS JAMES — SVP, Finance & Accounting
Jan 27, 2026
Sale
Shares
2,226
Price
$8.46
Total Value
$18.83K
Shares Held After
150,083
% of Holdings
1.5%

Kura Oncology, Inc. (KURA)

Burrows Francis — Chief Scientific Officer
Jan 27, 2026
Sale
Shares
1,311
Price
$8.46
Total Value
$11.09K
Shares Held After
32,424
% of Holdings
3.9%

Kura Oncology, Inc. (KURA)

Bair Teresa Brophy — Chief Legal Officer
Jan 27, 2026
Sale
Shares
4,777
Price
$8.46
Total Value
$40.42K
Shares Held After
226,931
% of Holdings
2.1%

Kura Oncology, Inc. (KURA)

Bair Teresa Brophy — Chief Legal Officer
Jan 27, 2026
Sale
Shares
2,335
Price
$8.46
Total Value
$19.76K
Shares Held After
231,708
% of Holdings
1.0%

Kura Oncology, Inc. (KURA)

Bair Teresa Brophy — Chief Legal Officer
Jan 27, 2026
Sale
Shares
4,096
Price
$8.46
Total Value
$34.66K
Shares Held After
234,043
% of Holdings
1.7%

Acumen Pharmaceuticals, Inc. (ABOS)

Meisner Derek M — Chief Legal Officer & Corp Sec
Jan 26, 2026
Sale
Shares
15,085
Price
$3.00
Total Value
$45.26K
Shares Held After
173,999
% of Holdings
8.0%

Harmony Biosciences Holdings, Inc. (HRMY)

Kapadia Sandip — CHIEF FINANCIAL OFFICER
Jan 26, 2026
Sale
Shares
3,746
Price
$37.15
Total Value
$139.17K
Shares Held After
24,521
% of Holdings
13.3%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Jan 26, 2026
Sale
Shares
7,875
Price
$471.91
Total Value
$3.72M
Shares Held After
0
% of Holdings
100.0%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Jan 26, 2026
Sale
Shares
14,625
Price
$471.91
Total Value
$6.90M
Shares Held After
0
% of Holdings
100.0%

Liquidia Corp (LQDA)

Boyle Dana — Chief Accounting Officer
Jan 26, 2026
Sale
Shares
1,580
Price
$41.65
Total Value
$65.81K
Shares Held After
178,848
% of Holdings
0.9%

Liquidia Corp (LQDA)

Adair Jason — Chief Business Officer
Jan 26, 2026
Sale
Shares
688
Price
$41.65
Total Value
$28.66K
Shares Held After
211,169
% of Holdings
0.3%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Jan 26, 2026
Sale
Shares
6,418
Price
$5.02
Total Value
$32.22K
Shares Held After
593,185
% of Holdings
1.1%

Milestone Pharmaceuticals Inc. (MIST)

Bharucha David — Chief Medical Officer
Jan 26, 2026
Sale
Shares
12,245
Price
$1.93
Total Value
$23.63K
Shares Held After
113,181
% of Holdings
9.8%

Milestone Pharmaceuticals Inc. (MIST)

Nelson Jeffrey Edward — Chief Operating Officer
Jan 26, 2026
Sale
Shares
12,245
Price
$1.93
Total Value
$23.63K
Shares Held After
49,848
% of Holdings
19.7%

Milestone Pharmaceuticals Inc. (MIST)

Muller Lorenz — Chief Commercial Officer
Jan 26, 2026
Sale
Shares
11,180
Price
$1.93
Total Value
$21.58K
Shares Held After
205,406
% of Holdings
5.2%

Milestone Pharmaceuticals Inc. (MIST)

Hasija Amit — CFO & EVP of Corp. Development
Jan 26, 2026
Sale
Shares
12,245
Price
$1.93
Total Value
$23.63K
Shares Held After
99,848
% of Holdings
10.9%
Jan 26, 2026
Sale
Shares
34,523
Price
$1.93
Total Value
$66.63K
Shares Held After
482,744
% of Holdings
6.7%
Jan 26, 2026
Purchase
Shares
11,709
Price
$8.54
Total Value
$99.99K
Shares Held After
279,481
% of Holdings
4.2%
Jan 26, 2026
Purchase
Shares
11,709
Price
$8.54
Total Value
$99.99K
Shares Held After
19,618
% of Holdings
59.7%
Jan 26, 2026
Sale
Shares
14,205
Price
$84.05
Total Value
$1.19M
Shares Held After
574,505
% of Holdings
2.4%
Jan 26, 2026
Sale
Shares
10,685
Price
$84.00
Total Value
$897.54K
Shares Held After
574,505
% of Holdings
1.8%

Protagonist Therapeutics, Inc (PTGX)

MOLINA ARTURO MD — Chief Medical Officer
Jan 26, 2026
Sale
Shares
5,000
Price
$82.28
Total Value
$411.40K
Shares Held After
84,115
% of Holdings
5.6%

NewAmsterdam Pharma Co N.V. (NAMS)

Kooij Louise Frederika — Chief Accounting Officer
Jan 26, 2026
Sale
Shares
309
Price
$33.45
Total Value
$10.34K
Shares Held After
24,353
% of Holdings
1.3%

NewAmsterdam Pharma Co N.V. (NAMS)

Kooij Louise Frederika — Chief Accounting Officer
Jan 26, 2026
Sale
Shares
34,091
Price
$32.77
Total Value
$1.12M
Shares Held After
24,662
% of Holdings
58.0%
Jan 26, 2026
Sale
Shares
26,918
Price
$4.61
Total Value
$124.09K
Shares Held After
1,317,389
% of Holdings
2.0%
Jan 26, 2026
Sale
Shares
41,312
Price
$4.61
Total Value
$190.45K
Shares Held After
2,908,257
% of Holdings
1.4%

Taysha Gene Therapies, Inc. (TSHA)

Alam Kamran — CHIEF FINANCIAL OFFICER
Jan 26, 2026
Sale
Shares
23,849
Price
$4.61
Total Value
$109.94K
Shares Held After
1,443,786
% of Holdings
1.6%

Mirum Pharmaceuticals, Inc. (MIRM)

BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Jan 26, 2026
Sale
Shares
1,053
Price
$96.19
Total Value
$101.29K
Shares Held After
43,741
% of Holdings
2.4%

Mirum Pharmaceuticals, Inc. (MIRM)

Radovich Peter — PRESIDENT AND COO
Jan 26, 2026
Sale
Shares
3,143
Price
$96.19
Total Value
$302.33K
Shares Held After
23,286
% of Holdings
11.9%

Mirum Pharmaceuticals, Inc. (MIRM)

Howe Jolanda — SVP, GLOBAL CONTROLLER
Jan 26, 2026
Sale
Shares
842
Price
$96.19
Total Value
$80.99K
Shares Held After
3,700
% of Holdings
18.5%
Jan 26, 2026
Sale
Shares
6,831
Price
$96.19
Total Value
$657.09K
Shares Held After
169,402
% of Holdings
3.9%

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Huntsman Carole — Chief Commercial Officer
Jan 26, 2026
Sale
Shares
570
Price
$494.59
Total Value
$281.92K
Shares Held After
9,122
% of Holdings
5.9%

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Huntsman Carole — Chief Commercial Officer
Jan 26, 2026
Sale
Shares
340
Price
$492.42
Total Value
$167.42K
Shares Held After
9,692
% of Holdings
3.4%
Jan 26, 2026
Sale
Shares
1,577
Price
$492.42
Total Value
$776.55K
Shares Held After
148,497
% of Holdings
1.1%
Jan 26, 2026
Sale
Shares
647
Price
$492.42
Total Value
$318.60K
Shares Held After
452,704
% of Holdings
0.1%
Jan 23, 2026
Sale
Shares
8,135
Price
$30.01
Total Value
$244.15K
Shares Held After
419,173
% of Holdings
1.9%
Jan 23, 2026
Sale
Shares
19,315
Price
$84.59
Total Value
$1.63M
Shares Held After
574,505
% of Holdings
3.3%
Version: v26.3.33